CAS号 | 名称 | 物化性质 | 分子式 | 分子量 |
26675-76-3 | mycophenolate mofetil related compound b | |
C17H20O6 | 320.34 |
176591-32-5 | musk active human | |
| |
753517-83-8 | mortalin (47-end), gst tagged human | |
| |
60450-21-7 | 檄树素苷 morindin | |
| |
103733-51-3 | moexipril related compound b | 熔点:74-77 °C
|
C27H32N2O6 | 480.55 |
191359-13-4 | mnk1 active human | |
| |
153190-46-6 | mlk3 (1-488), active, gst tagged human | |
| |
744270-00-6 | ml116 | |
| |
681847-92-7 | ml 00253764 hydrochloride | |
| |
1354707-41-7 | α-[2-(2,4-difluorophenyl)-2-oxoethyl]-1h-indole-3-acetic acid mitochonic acid 5 | |
C18H13F2NO3 | 329.3 |
862189-96-6 | mirodenafil dihydrochloride | |
C26H39Cl2N5O5S | 604.59 |
119637-66-0 | metoprolol fumarate | |
| |
61919-52-6 | 11β-hydroxy-6α-methylandrosta-1,4-diene-3,17-dione methylprednisolone related compound c | |
C20H26O3 | 314.42 |
119657-85-1 | methylprednisolone hemisuccinate rcd | 熔点:221-223 °C
|
C26H36O8 | 476.56 |
27475-26-9 | methyl5-[2-[benzyl(tert-butyl)amino]acetyl]-2-hydroxybenzoate hydrochloride | |
| |
1160919-46-9 | 3-[[(2rs)-2-溴丙酰基]氨基]-4-甲基噻吩-2-羧酸甲酯 methyl 3-[[(2rs)-2-bromopropanoyl]amino]-4-methylthiophene-2-carboxylate | |
| |
23964-59-2 | methyl 3-[[(2rs)-2-(butylamino)propanoyl]amino]-4-methylthiophene-2- carboxylate hydrochloride | |
C14H23ClN2O3S | 334.86 |
59899-89-7 | methyl 2-(1,2-benzisoxazol-3-yl)acetate | |
| |
5259-86-9 | methyl [(4-aminobenzoyl)amino]acetate | |
| |
856307-27-2 | 4-甲基氨基安替比林 盐酸盐 metamizole impurity c | |
C12H16ClN3O | 253.73 |
104390-56-9 | (±)-2-[(1-carboxyethyl)(methoxyacetyl)amino]-3-methylbenzoic acid metalaxyl metabolite cga 108906 | |
| |
33103-93-4 | memantine related compound g | |
C11H20ClN | 201.74 |
480083-12-3 | mor2 | |
| |
1776116-74-5 | 5-[(4-[1,1′-biphenyl]-4-yl-1,6-dihydro-6-oxo-2-pyrimidinyl)thio]-n-hydroxypentanamide mc1742 | |
| |
1396823-27-0 | mbp, gst标记 人 mbp, gst tagged human | |
| |
1895861-88-7 | may0132 | |
| |
88497-88-5 | 木脂素b manassantin b | |
| |
827327-28-6 | malat1-in-5 | 密度:1.14±0.1 g/cm3(Predicted) 沸点:534.0±60.0 °C(Predicted)
|
C19H21N3O2 | 323.395 |
1334178-05-0 | mal-dpeg®4-(m-dpeg®12)3 | |
C106H202N6O50 | 2360.75 |
1334172-73-4 | mal-dpeg®11-lipoamide | |
C39H69N3O15S2 | 884.11 |
1599466-63-3 | m090 | |
| |
1334169-90-2 | m-dpeg®8-mal | |
C24H42N2O11 | 534.6 |
1334172-67-6 | m-dpeg®8-lipoamide | |
C25H49NO9S2 | 571.8 |
1263044-81-0 | m-dpeg®4-mal | |
C16H26N2O7 | 358.39 |
88504-24-9 | m-dpeg®12-mal | |
C32H58N2O15 | 710.81 |
1334172-68-7 | m-dpeg®12-lipoamide | |
C33H65NO13S2 | 748 |
96400-45-2 | 3′,4′,5,7-tetrahydroxyflavone 7-diglucuronide luteolin 7-diglucuronide | 密度:1.94±0.1 g/cm3 沸点:1101.6±65.0 °C
|
C27H26O18 | 638.48 |
53965-08-5 | luteolin 3′,7-di-o-glucuronide
| |
| |
1187020-80-9 | 4-((6br,10as)-3-methyl-2,3,6b,9,10,10a-hexahydro-1h,7h-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-1-(4-fluorophenyl)-butan-1-one 4-methylbenzenesulfonate lumateperone tosylate | |
C31H36FN3O4S | 565.7 |
1252362-53-0 | lre1 | |
C12H13ClN4S | 280.78 |
77517-29-4 | lovastatin related compound a | |
| |
149756-62-7 | lovastatin impurity d | |
| |
1334172-70-1 | lipoamido-dpeg®8-acid | |
C27H51NO11S2 | 629.82 |
1334172-71-2 | lipoamido-dpeg®12-acid | |
C35H67NO15S2 | 806.03 |
489-33-8 | 3,4′,5,7-tetrahydroxy 3′,8-dimethoxyflavone limocitrin | |
C17H14O8 | 346.293 |
7606-29-3 | levomepromazine sulfoxide | |
| |
174607-68-2 | (r)-α-{[(1,1-dimethylethyl)amino]methyl}-4-(phenylmethoxy)-1,3-benzenedimethanol levalbuterol related compound f | 密度:1.120±0.06 g/cm3(Predicted) 沸点:510.1±50.0 °C(Predicted)
|
C20H27NO3 | 329.43 |
2393840-15-6 | lei-401 | |
| |
184582-62-5 | ldn-192960 dihydrochloride | |
C18H20N2O2S | 328.43 |
1000269-30-6 | lcat activator compound a | |
| |